Multidisciplinary Clinical Science Committee

The Multidisciplinary Clinical Science Committee at the IASLC comprises leading experts and researchers in the field of clinical thoracic oncology who will tackle key scientific questions in the diagnosis, treatment, and management of thoracic malignancies worldwide.

Mission

The Clinical Science Committee plays a pivotal role in advancing the field through its research initiatives, education, and advocacy efforts. By fostering collaboration and innovation, the committee aims to improve patient outcomes, enhance the quality of care, and contribute to the eradication of thoracic malignancies worldwide.

Committee projects

Expert Panel & Consensus Statement: Defining Multidisciplinary Care for Thoracic Cancers

This project aims to provide an expert consensus definition of multidisciplinary care by evaluating differences in the composition of multidisciplinary teams, the time taken for evaluation by a multidisciplinary team, and the barriers to providing multidisciplinary care across various institutions, regions, or settings. The first phase of the project will involve a guidelines and literature review addressing multidisciplinary care.

Decision-Making Analysis & Manuscript: Understanding treatment Decisions & Discrepancies in Stage III NSCLC Care for Borderline Resectable Disease

One of the first initiatives of the Multidisciplinary Clinical Science Committee is to utilize objective consensus methodology among a group of multidisciplinary experts to identify overlaps or discrepancies in decision-making criteria, treatment options, and treatment decisions for Stage III NSCLC. This approach aims to pinpoint meaningful divergences in the decision-making process, which will be reported in a manuscript and will inform areas of focus for future projects.

Synoptic Procedural Reporting for Quality Assessment in Systematic Staging EBUS in NSCLC

Systematic staging is recommended for patients with clinical stage I-III NSCLC. This project seeks to establish standards for and implement synoptic reporting for systematic lymph node staging using endobronchial ultrasound (EBUS). The implementation of these standards will improve the quality of systematic lymph node staging where recommended, aiming to reduce variance in care and enhance the quality of EBUS staging.

2024 Radiation Oncology Webinar

The purpose of the webinar is to provide an annual update on new developments in Radiation Oncology within the increasingly multidisciplinary care for all stages and types of lung cancers. Highlights will include impactful studies from the recent ELCC and ESTRO scientific meetings, as well as new practice-changing radiation publications. As radiation continues to play a crucial role in the treatment of all stages and subtypes of lung cancer, this webinar aims to address some of the gaps for both radiation and non-radiation oncology healthcare professionals.

Chair of Committee

Tracy Leong

2025-2027

2025-2027 Roster

Thomas Newsom-Davis

United Kingdom

Chelsea and Westminster Hospital

Deputy Committee Chair

Joe Chang

United States

MD Anderson Cancer Center in Houston, TX

Board Liaison

Keelan Zius

United States

International Association for the Study of Lung Cancer

Staff Liaison

Fernando Abrao

Brazil

Hospital Alemao Oswaldo Cruz

Committee Member

Guntulu Ak

Turkey

Eskisehir Osmangazi University Medical Faculty

Committee Member

Hata Akito

Japan

Kobe Minimally Invasive Cancer Center

Committee Member

Arya Amini

United States

City of Hope National Medical Center

Committee Member

Ayse Ece Cali Daylan

United States

Washington University in St. Louis

Committee Member

Houda Bahig

Canada

Centre Hospitalier de l'Université de Montréal

Committee Member

Tithi Biswas

United States

University of Florida

Committee Member

Shamus Carr

United States

National Institutes of Health

Committee Member

Pei-Hsing Chen

Taiwan

National Taiwan University Hospital

Committee Member

Xiaohui Chen

China

Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital

Committee Member

Stephen Chun

United States

MD Anderson Cancer Center

Committee Member

Alissa Cooper

United States

Memorial Sloan Kettering Cancer Center

Committee Member

Luis Corrales-Rodriguez

Costa Rica

CCSS-ICOT-Clinica Biblica

Member

Gilberto De Castro Junior

Brazil

Instituto do Câncer do Estado de São Paulo - ICESP

Committee Member

Wentao Fang

China

Shanghai East Hospital , Shanghai Tongji University

Committee Member

Andrea Filippi

Italy

University of Milan and Istituto Nazionale Tumori, Milan

Committee Member

Pier Luigi Filosso

Italy

Baggiovara Civil Hospital

Committee Member

Bailey Fitzgerald

United States

Roswell Park Comprehensive Cancer Center

Committee Member

Erin Gillaspie

United States

Creighton University Medical Center

Committee Member

Ken Harada

Japan

Tohoku University

Committee Member

Julia Judd

United States

Fox Chase Cancer Center

Committee Member

Jin Kang

China

Guangdong Lung Cancer Institute

Committee Member

Sam Khan

England

University of Leicester

Committee Member

Divya Khosla

India

Postgraduate Institute of Medical Education and Research (PGIMER)

Committee Member

Saadettin Kilickap

Istanbul

Istinye University Faculty of Medicine

Committee Member

Florence Keane

United States

Massachusetts General Hospital

Committee Member

Feng-Ming Spring Kong

China

The University of Hong Kong

Committee Member

Milica Kontic Jovanovic

Serbia

University Clinical Centre of Serbia

Committee Member

Vincent Lam

United States

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Committee Member

Xiuning Le

United States

The University of Texas MD Anderson Cancer Center

Committee Member

David Lee

Malaysia

Sunway Medical Centre

Committee Member

Alexander Louie

Canada

Sunnybrook Health Sciences Centre

Committee Member

Kristen Marrone

United States

Johns Hopkins University School of Medicine

Committee Member

Clarissa Mathias

Brazil

Nucleo de Oncologia da Bahia

Committee Member

Vanessa Costa Menezes

Canada

Complexo Hospitalar Universitario da Universidade Federal da Bahia

Committee Member

Yaw Mensah

Ghana

University of Ghana Medical School

Committee Member

Pablo Munoz Schuffenegger

Chile

Pontificia Universidad Católica de Chile

Committee Member

Sara Pilotto

Italy

University of Verona

Committee Member

Daniel Przybysz

Brazil

RadioSerra Radiation Therapy

Committee Member

Paul Martin Putora

Switzerland

Kantonsspital St. Gallen

Committee Member

Angel Qin

United States

University of Michigan

Committee Member

Biagio Ricciuti

United States

Dana-Farber Cancer Institute

Committee Member

Shankar Siva

Australia

Peter MacCallum Cancer Center

Committee Member

Tom Stinchcombe

United States

Duke Cancer Institute

Committee Member

Xuqi Sun

China

The First Affiliated Hospital, Zhejiang University School of Medicine

Committee Member

Michael Tjong

Canada

Odette Cancer Centre, Sunnybrook HSC

Committee Member

Akif Turna

Turkey

Istanbul University Cerrahpasa Medical School

Committee Member

Vamsidhar Velcheti

United States

New York University School of Medicine

Committee Member

Gerard Walls

United Kingdom

Queen's University Belfast

Committee Member

William Nassib William Jr.

Brazil

Grupo Oncoclínicas

Committee Member

Yang Xia

China

Second Affiliated Hospital of Zhejiang University School of Medicine

Committee Member

Nathan Yu

United States

Mayo Clinic

Committee Member

Yang Zhang

China

Shanghai Chest Hospital

Committee Member

Chao Zhang

China

Committee Member

Hongcheng Zhu

China

Fudan University Shanghai Cancer Center

Committee Member

Committee Responsibilities:

Identify and prioritize research areas and topics of significant clinical relevance in thoracic malignancies.
Promote collaboration and knowledge exchange among researchers and institutions globally.
Encourage the development of innovative research methodologies and approaches to improve clinical outcomes.
Foster partnerships to support research initiatives.
Promote patient recruitment and engagement in clinical trials through educational campaigns and advocacy.
Encourage data sharing and collaboration among researchers to enhance statistical power and derive meaningful insights.
Promote the utilization of advanced analytics and artificial intelligence techniques for data analysis.
Organize scientific meetings, symposia, and workshops to disseminate the latest research findings and advancements in thoracic oncology.
Develop educational resources, guidelines, and position papers to guide clinical practice and inform healthcare professionals, patients, and the public.
Collaborate with other IASLC committees and external organizations to deliver comprehensive educational programs and materials.
Foster mentorship programs to support early-career researchers and clinicians in the field of thoracic malignancies.

Committee Nominations for the 2025-2027 term are now closed.

New Committee Nominations will take place again in 2027.

Let us know if you're interested in applying in 2027 here